Literature DB >> 20592566

Pediatric epilepsy syndromes.

Deivasumathy Muthugovindan1, Adam L Hartman.   

Abstract

BACKGROUND: Pediatric epilepsies are a heterogeneous group of disorders that encompass various epilepsy syndromes ranging from benign to progressive and catastrophic. The past 2 decades have seen major advancements in the appreciation of epilepsy syndromes and their underlying mechanisms. Modern neuroimaging methods have helped to identify structural pathologies and genetic discoveries led to identifying new syndromes and characterization of old syndromes. Epilepsy syndromes are categorized on the basis of a number of features including seizure types, age of onset, clinical features, electroencephalographic expression, and response to treatment. Multiple seizure types, evolution from one type to and another and age-dependent expression are some of the unique features of epilepsy syndromes. The International League Against Epilepsy uses the age-related expression of these syndromes and classifies them by different age groups, allowing easy identification. Early recognition and identification of epilepsy syndromes is essential to provide valuable information on management and prognosis. REVIEW
SUMMARY: The purpose of this article is to review the literature data on the prevalence, clinical manifestations, electrographic findings, pathophysiology, prognosis, and treatment options for these syndromes.
CONCLUSIONS: Accurate and early diagnosis of epilepsy syndrome, when possible, is essential for both evaluation and treatment because specific antiepileptic therapies are increasingly recognized.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592566     DOI: 10.1097/NRL.0b013e3181d9d6b7

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  2 in total

Review 1.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

2.  A Novel SCN1A Mutation: A Case Report.

Authors:  Mahmut Aslan; Bilge Ozgor; Serkan Kirik; Serdal Gungor
Journal:  J Pediatr Neurosci       Date:  2020-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.